Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22
2013 Standout
Emergence of Quinolone-Resistant Escherichia coli Bacteremia in Neutropenic Patients with Cancer Who Have Received Prophylactic Norfloxacin
1995
Vulvovaginal candidosis
2007 Standout
Adrenal cortical carcinoma: Survival after radiotherapy
1987
Gastric Colonization of Candida albicans Differs in Mice Fed Commercial and Purified Diets
2005
Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study
2009
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
Treatment of Candida albicans fungaemia with fluconazole
1993
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Virulence factors of Candida albicans
2001 Standout
Cushing's syndrome
2015 Standout
Secondary mycosis in surgery: Treatment with fluconazole
1989
Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia
1991
CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS
1989
The pathology of fungal infection and colonization in patients with cystic fibrosis
1989
Cremophor EL
2001 Standout
Paclitaxel (Taxol)
1995 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Clinical applications of quinone-containing alkylating agents
2000
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Nosocomial acquisition of Candida parapsilosis: An epidemiologic study
1993
Methicillin-Resistant Staphylococcus aureus
1989 Standout
Skin Hygiene and Infection Prevention: More of the Same or Different Approaches?
1999 Standout
Cardiotoxicity of Chemotherapeutic Agents
2000
Guidelines of care for superficial mycotic infections of the skin: Mucocutaneous candidiasis
1996
Problems and Controversies in the Management of Hematogenous Candidiasis
1996
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study.
1993
Improving Adherence to Hand Hygiene Practice: A Multidisciplinary Approach
2001 Standout
Clinical Pharmacology of 5-Fluorouracil
1989 Standout
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
1994
Melioidosis: A Major Cause of Community-Acquired Septicemia in Northeastern Thailand
1989 Standout
Cardiac disturbances during the administration of taxol.
1991
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery
1995
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia
2005
Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report
1993
Cytokines as therapy for opportunistic fungal infections
1998
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Antineoplastic Drugs
1978
Gram-Negative Rod Bacteremia: Microbiologic, Immunologic, and Therapeutic Considerations
1977
5‐Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma
1991
Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycin
1981 StandoutNobel
In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species
1997
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma
2000
Risk factors for candidemia in cancer patients: a case-control study
1988
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice
1992
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Nosocomial Fungal Infections
1989
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
The treatment of adrenocortical carcinoma with o,p′-DDD: Prognostic simplications of serum level monitoring
1984
Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients
1983 Standout
Increased incidence of fungemia caused by Candida krusei
1986
Current and Emerging Azole Antifungal Agents
1999 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
An Outbreak of Pneumocystis carinii Pneumonia in Homosexual Men
1982
Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA
1980
Control and Eradication of Methicillin-ResistantStaphylococcus aureuson a Surgical Unit
1984
Cooperative sequestration of m-AMSA in L1210 cells
1982 StandoutNobel
Bacteremia Due To Pseudomonas aeruginosa Complicating Neoplastic Disease: A Progress Report
1974
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory Concentration
1987 Standout
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
1987 StandoutNobel
Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
1999
Gram-negative bacteremia
1980 Standout
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
2005 Standout
Synergy of Carbenicillin and Gentamicin in Experimental Infection with Pseudomonas
1971
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Marine natural products
2018 Standout
4′-(9-Acridinylamino) Methanesulfon-m-Anisidide (AMSA): A New Drug Effective in the Treatment of Adult Acute Leukemia
1980
Pseudomonas aeruginosa Resistant to Carbenicillin and Gentamicin
1973
Aspergillus fumigatusand Aspergillosis
1999 Standout
Induction of spermidine/spermine N1-acetyltransferase by methylglyoxal bis(guanylhydrazone)
1985
Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis
1996
Carbenicillin Therapy for Pseudomonas Infections
1971
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1
2016
Rapid Detection and Identification ofCandida,Aspergillus, andFusariumSpecies in Ocular Samples Using Nested PCR
2000
Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.
1983 StandoutNobel
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and Granulocytopenia
1971
Amikacin and Cephalothin: Empiric Regimen for Granulocytopenic Cancer Patients
1977
A role for complement receptor-like molecules in iron acquisition by Candida albicans.
1992
Guidelines for Treatment of Candidiasis
2004 Standout
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy
1982
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Formation and resealing of intercalator-induced DNA strand breaks in permeabilized L1210 cells without the stimulated synthesis of poly(ADP-ribose).
1982 StandoutNobel
Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults
1982
Recent advances in the biochemistry of polyamines in eukaryotes
1986 Standout
Works of Bodey Gp being referenced
Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.
1980
Approaches to the treatment of acute leukemia and lymphoma in adults.
1978
High-dose AMSA and bone marrow rescue in patients with solid tumors.
1982
Evaluation of a bacteriostatic soap, P-300, on skin flora of patients in protected environments.
1973
Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
1980
Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.
1980
Antimicrobial prophylaxis for infection in neutropenic patients.
1988
Pneumocystis carinii pneumonitis in cancer patients.
1972
Therapy of infections with the combination of carbenicillin and gentamicin.
1969
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
1983
Phase II study of anguidine in advanced breast cancer.
1979
Candidiasis in cancer patients.
1984
Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
1981
Phase I-II evaluation of cyclocytidine.
1977
Cytotoxic chemotherapy in adrenal cortical carcinoma.
1981